Reality Defender Expands Series A to $33 Million to Enhance AI Detection Capabilities Reality Defender
Equilibrium Energy Signs New Battery Tolls, Enters California, Celebrates Its Market-Leading Battery Management Performance, Welcomes New Executive Hires, and Closes Its Series B Fundraise Equilibrium Energy
Tidal Metals Announces $8.5 Million Series Seed Funding Led by DCVC for Revolutionary Technology to Safely and Economically Extract Magnesium Metal from Seawater Tidal Metals
Twelve Announces $645 Million in Funding Led by TPG to Transform CO2 into Jet Fuel and Electrochemicals at Scale Twelve
Syntax Bio Launches with Strategic Backing from Astellas Venture Management LLC and Illumina Ventures Syntax Bio
unspun Raises $32M in Oversubscribed Series B Funding to Transform Fashion Supply Chains with Groundbreaking 3D Weaving Technology Unspun
Valar Labs Announces $22 Million Series A to Advance Vesta, First AI Diagnostic Test to Predict Treatment Response in Bladder Cancer, and Catalyze Expansion in Other Cancers Valar Labs
Avicenna Introduces Machine Learning-Enhanced Medicinal Chemistry Platform to Accelerate the Last Mile of Small Molecule Drug Discovery Avicenna Biosciences
Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing Latus Bio
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm Relation
Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology Unlearn
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection Freenome
TCarta and Capella Space Partner to Leverage All-weather SAR Imagery for Coastline Management Capella Space
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference Recursion Pharmaceuticals
Plexium Initiates Dosing in Phase 1 Study of PLX-4545, a Potent and Selective Degrader of the Transcription Factor IKZF2 Plexium
Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets Solu Therapeutics
Top Sustainability VCs Lead $US28 Million Series B for Australian Breakthrough Mining Tech Plotlogic Plotlogic
NASA Selects Zeno to Lead Team to Develop Radioisotope Power System for Lunar Applications Zeno Power
Climate Breakthrough: Brimstone’s Decarbonized Portland Cement First to Meet Essential Building Industry Standard, Unlocking the Potential of Net-Zero Construction Brimstone
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery Recursion Pharmaceuticals
Oklo, an Advanced Fission Technology Company, to Go Public via Merger with AltC Acquisition Corp. Oklo
Twelve Commences Construction of First Commercial-Scale Plant in US for Producing Sustainable Aviation Fuel from CO2 Twelve
Databricks Signs Definitive Agreement to Acquire MosaicML, a Leading Generative AI Platform Databricks MosaicML
Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development Kanvas Biosciences
Nium raises funds to replace Haber-Bosch, the most polluting chemical industrial process on Earth Nium
Demox Labs Launches Leo Wallet and Raises $4.5 Million To Build Zero Knowledge Proof Blockchain Infrastructure Demox Labs
Twelve and Etihad Airways partner to advance sustainable aviation fuel made from CO2 and renewable energy Twelve
LiveEO and Capella Space Partner to bring High-Speed, High-Resolution SAR Satellite Insights to Asset Managers Capella Space
MosaicML Launches Inference API and Foundation Series for Generative AI; Leading Open Source GPT Models, Enterprise-Grade Privacy and 15x Cost Savings MosaicML
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge Ascend Advanced Therapies
First Light Field-Enabled Spine Surgery Navigation Platform, Proprio Paradigm™, Receives FDA Clearance Proprio
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors Totus Medicines